UpHealth, Inc.: Nasdaq/NYSE listing notice — UpHealth warrants (UPH.WS) delisted from NYSE due to abnormally low price; now trading OTC

UpHealth, Inc.

NYSE Regulation determined warrants unsuitable for listing due to 'abnormally low' price levels under Section 802.01D.
Trading in warrants suspended immediately on Nov 28, 2023; company does not intend to appeal.
Warrants began trading over-the-counter on Nov 29 under symbol UPHLW.
Common stock (UPH) remains listed on NYSE; delisting does not affect operations or SEC reporting.
Transition to OTC likely reduces liquidity and could further depress warrant trading price.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

UpHealth, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

Exchange: nyse
Notice: delisting notice
Rules: 802.01D

Exact text from the filing

November 28, 2023, UpHealth, Inc. (the “Company”) received written notice from the staff of NYSE Regulation (“NYSE Regulation”) that it has determined to commence proceedings to delist the Company’s redeemable warrants, exercisable for one share of common stock of the Company at an exercise price of $115.00 per share (ticker symbol: UPH.WS) (the “Warrants”), from the New York Stock Exchange (the “NYSE”) and that trading in the Warrants was suspended immediately. NYSE Regulation reached its determination that the Company’s Warrants are no longer suitable for listing based on “abnormally low” pr

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001628280-23-040224

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.